← FDA DRUG APPROVALS

FDA ANDA · ANDA214308

SUCCINYLCHOLINE CHLORIDE

Sponsor: REGCON HOLDINGS

APPLICATION
ANDA214308
TYPE
ANDA
ORIGINAL APPROVAL
2020-05-22
LATEST ACTION
2021-10-29
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

SUCCINYLCHOLINE CHLORIDEPrescription
SUCCINYLCHOLINE CHLORIDE 20MG/ML · INJECTABLE · INJECTION

Approval history

2021-10-29Labeling · Supplement 4 · standardAP
2020-11-05Manufacturing (CMC) · Supplement 2 · standardAP
2020-05-22UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →